Background-Pulmonary hypertension (PH) is a lethal syndrome associated with the pathogenic remodeling of the pulmonary vasculature and the emergence of apoptosis-resistant cells. Apoptosis repressor with caspase recruitment domain (ARC) is an inhibitor of multiple forms of cell death known to be abundantly expressed in striated muscle. We show for the first time that ARC is expressed in arterial smooth muscle cells of the pulmonary vasculature and is markedly upregulated in several experimental models of PH. In this study, we test the hypothesis that ARC expression is essential for the development of chronic hypoxia-induced PH. Methods and Results-Experiments in which cells or mice were rendered ARC-deficient revealed that ARC not only protected pulmonary arterial smooth muscle cells from hypoxia-induced death, but also facilitated growth factor-induced proliferation and hypertrophy and hypoxia-induced downregulation of selective voltage-gated potassium channels, the latter a hallmark of the syndrome in humans. Moreover, ARC-deficient mice exhibited diminished vascular remodeling, increased apoptosis, and decreased proliferation in response to chronic hypoxia, resulting in marked protection from PH in vivo. Patients with PH have significantly increased ARC expression not only in remodeled vessels but also in the lumen-occluding lesions associated with severe disease. Conclusions-These data show that ARC, previously unlinked to pulmonary hypertension, is a critical determinant of vascular remodeling in this syndrome. (Circulation. 2011;124:2533-2542.)
P ulmonary hypertension (PH), defined clinically as an elevation in the mean pulmonary arterial pressure Ͼ25 mm Hg, is a life-threatening syndrome involving structural and functional changes in the pulmonary vasculature. These abnormalities result in increased pulmonary vascular resistance (PVR), right ventricular hypertrophy, and right heart failure. [1] [2] [3] Current therapies are costly and have limited efficacy. 4, 5 
Clinical Perspective on p 2542
Vascular remodeling in pulmonary hypertension involves the entire vessel and multiple cellular components, including smooth muscle cells, endothelial cells, and adventitial fibroblasts. Increased proliferation and hypertrophy in concert with decreased cell death/apoptosis of pulmonary arterial smooth muscle cells (PASMCs) contribute to the medial thickening and neomuscularization of distal arterioles characteristic of all forms of pulmonary hypertension. These changes result in reduction of the inner luminal diameter and/or enhanced vasoconstriction of pulmonary vessels and increased PVR. 6, 7 PH-associated vascular remodeling can be induced by multiple pathophysiologic stimuli (hypoxemia, anorexigens, aberrant flow), and is influenced by genetics. 8 Although their roles in the pathogenesis of PH are incompletely understood, several molecular changes correlate with its development. Voltage-gated potassium (K v ) channels re-sponsible for maintaining the resting membrane potential of the cell are downregulated in PH and associated with increased proliferation and decreased apoptosis of PASMCs. 9, 10 Hypoxia also induces endothelin-1 and 5-hydoxytryptamine (serotonin) release, which respectively increase PASMC proliferation and hypertrophy. [11] [12] [13] [14] Inhibition of each of these pathways attenuates the development of pulmonary hypertension. 15, 16 Apoptosis repressor with caspase recruitment domain (ARC) is an endogenous inhibitor of cell death that is expressed primarily in cardiac and skeletal myocytes. 17, 18 It is unusual among death repressors in that it blocks multiple modes of cell death, including that initiated by the extrinsic (death receptor) or intrinsic (mitochondrial/ER) apoptosis pathways, as well as oxidative stress-induced caspaseindependent cell death. 18 -22 As such, ARC is a tissuerestricted suppressor of multiple cell death pathways.
Because the establishment of an apoptosis-resistant state has been implicated in the pathogenesis of PH, 23 the purpose of this investigation was to determine whether ARC plays a role in the chronic hypoxia (CH)-induced vascular remodeling associated with the development of PH. We show for the first time that ARC is expressed in the lung vasculature, and that this expression is increased in the PASMCs of mice and rats exposed to chronic hypoxia or in rats with monocrotaline-induced PH. ARC expression in isolated PASMCs confers resistance to CH-induced death while promoting proliferative and hypertrophic growth in response to pathophysiologically relevant stimuli. Moreover, mice lacking ARC are resistant to developing CH-induced pulmonary hypertension, exhibiting marked attenuation of pulmonary arterial vascular remodeling associated with increased apoptosis and decreased vascular cell proliferation. The clinical significance of these findings is underscored by increased ARC expression in the pulmonary vasculature and lumen-occluding lesions of patients with pulmonary arterial hypertension (PAH). These studies demonstrate that ARC plays an important role in the pathogenesis of CH-induced PH in the mouse and suggest that it may be of similar importance in the development of human PH.
Methods

Generation of the ARC-Deficient (nol3
؊/؊
) Mouse
A vector containing a neo-TK cassette and three loxP sites flanking mouse genomic nol3 sequences was targeted to the nol3 locus of 129/Sv embryonic stem cells. Chimeric mice were bred to C57Bl/6 mice to achieve heterozygous germline transmission and then to EIIA-Cre mice to create heterozygous nol3 knockout mice. These mice were then bred with C57Bl/6 mice for at least 6 generations. Nol3 heterozygotes were interbred to produce homozygous nol3 Ϫ/Ϫ mice and wild-type controls. Only male mice between 8 and 10 weeks old were used.
Chronic Hypoxia Model
Mice were exposed to 10% O 2 in a plexiglass chamber (Biospherix, Inc.) monitored by Pro:Ox oxygen controller (model 350; Reming Bioinstruments, Redfield, NY), as previously described. 24 
Hemodynamic Measurements
To obtain in vivo hemodynamic measurements, mice were anesthetized with a continuous stream of regulated oxygen containing 2% isoflurane. The mice were then ventilated with continuous isoflurane using a rodent ventilator set to 90 breaths/min with a tidal volume of 6 mL/kg body weight. The chest was opened with a midline incision, and a 4-electrode pressure-volume catheter (PVR-1035, IF, 3.5-mm spacing; Millar Instruments, Houston, TX) was then placed through the right ventricular apex to record chamber volume by impedance and pressure by micromanometry, as described previously. 25, 26 
Statistical Analyses
Statistical analysis was performed by 2-tailed t test for pair-wise comparisons or 1-way ANOVA for comparison between multiple groups using Bonferroni correction for posthoc, pair-wise between group comparisons for sample sizes of Ն5 per group. Smaller sample sizes (Յ4 per group) were compared using the nonparametric Kruskal-Wallis ANOVA test with Siegel (Bonferroni) correction for post hoc, pairwise contrasts. The random effects model ANOVA test was used to statistically evaluate comparisons that involved repeated measures. The minimal level of significance was set at PϽ0.05. Statistical analyses were performed using Analyze-It (General, version 1.73) for Microsoft Excel.
Additional details and methods are provided in the online-only Data Supplement Methods.
Results
ARC Is Expressed in the Pulmonary Vasculature and Upregulated by Chronic Hypoxia
ARC expression has been shown to be primarily restricted in normal tissues to terminally differentiated cells, such as cardiac and skeletal myocytes. We show here that ARC is also expressed in the large (Ͼ200 m diameter) extraparenchymal pulmonary arteries of rats and that this expression is substantially increased following exposure to CH (3 weeks, 10% O 2 ) ( Figure 1A ). Immunofluorescence staining of the intact lung confirmed CH-induced ARC expression in pulmonary arterial vessels, as colocalization of ARC with ␣-smooth muscle actin (SMA), a molecular marker of PASMCs, was minimal in the large vessels of rats maintained under normoxic conditions (N) ( Figure 1B ) but markedly elevated in rats exposed to CH (white arrows in Figure 1C ). This effect of CH on increasing medial ARC expression was also seen in the extraparenchymal pulmonary arteries (Ͼ100 m) of mice (online-only Data Supplement Figure IA and IB).
We next assessed ARC expression in small intrapulmonary arteries (diameter Ͻ200 m), the presumed sites of the pathological vascular remodeling in PH. Figure 1D (left panel) shows an example of a distal pulmonary artery (Ͻ50 m) from a normoxic rat in which ARC is clearly expressed in the adventitia (Adv) but only weakly in the medial cell layer (M). When exposed to CH, however, ARC expression is now clearly evident in the media cell layer ( Figure 1D , right panel and magnified inset), as well throughout the media of a larger intrapulmonary vessel (Ͼ50 m) ( Figure 1E) . A systematic analysis of the effect of CH on the expression of ARC revealed that colocalization of ARC and SMA was evident in only 13% (12.6Ϯ1.1%) of the small intrapulmonary vessels (20 -100 mol/L) under normoxia, but increased 3-fold (39.2Ϯ2.6%; N versus CH, PϽ0.001) in the vessels of animals exposed to CH ( Figure 1F ). An approximate 2.5-fold increase in ARC/SMA colocalization in larger intrapulmonary arteries (100 -250 mol/L diameter) was also observed. Similar effects in ARC expression and its colocalization with SMA were also seen in the small intrapul-monary vessels of the mouse lung (online-only Data Supplement Figure IC through IE) and in the vessels from rats with monocrotaline-induced PH ( Figure 1G through 1K) . Together, these data show that ARC is expressed in the rat and mouse pulmonary arterial vasculature and that its expression and colocalization with SMA increases in pulmonary resistance vessels in response to CH.
Endogenous Levels of ARC Suppress Hypoxia-Induced Cell Death in PASMCs
To assess the functional significance of ARC expression in the pulmonary vasculature, we employed an in vitro hypoxia model using early passage primary rat PASMCs. Hypoxia in vitro (4% O 2 /5% CO 2 /91% N 2 , 24 -72 hours) caused a marked increase in ARC mRNA and protein abundance ( Figure 2A and 2B, respectively), reaching a maximum within 24 hours of exposure and remaining elevated throughout the period of exposure. In contrast, microvascular endothelial cells expressed less ARC, which was reduced not increased by exposure to hypoxia (online-only Data Supplement Figure IIA) .
Although hypoxia can be a potent inducer of cell death, our data below show that isolated PASMCs are relatively resistant to cell death caused by hypoxia. To determine if this resistance is due to the expression of ARC, we transduced isolated PASMCs with an adenovirus expressing a shRNA designed to suppress ARC expression (Ad.545). Expression of the shRNA suppressed both the basal and hypoxia-induces in ARC mRNA ( Figure 2C ) and protein levels (Western blot inset to Figure 2D ). This reduction was not seen with sham-transduction (no adenovirus) or transduction with a control shRNA whose target sequence is not present in the human, mouse, or rat genomes (Ad.Neg). Although neither sham-nor Ad.Neg-transduced PASMCs showed a significant increase in cell death after 72 hours of hypoxia, apoptosis in Ad.545-transduced PASMCs was increased more than 10-fold ( Figure 2D ). Importantly, Ad.545 transduction in the absence of CH did not cause PASMC apoptosis (online-only Data Supplement Figure IIB ). In addition, nearly identical results were obtained using a second ARC shRNA targeting a different site in the ARC mRNA (online-only Data Supplement Figure IIC ). These data demonstrate that endogenous ARC expression is critical for PASMC resistance to hypoxiainduced death.
ARC Enhances the Proliferative and Hypertrophic Responses of PASMCs and Promotes the Hypoxia-Induced Reduction in Voltage-Gated Potassium Channel mRNA Abundance
Although ARC is most closely associated with the suppression of cell death in terminally differentiated cells, recent studies have shown that its abundance is markedly increased in human cancers and may play a role in potentiating growth-promoting pathways. [27] [28] [29] [30] We therefore investigated whether ARC plays a role in the response of PASMCs to endothelin-1 and serotonin (5-HT), growth factors closely linked to pulmonary hypertension. 11, 12, 16 Endothelin-1 elicited robust incorporation of 3 H-thymidine (DNA synthesis) in mock-and Ad.Neg-transduced cells ( Figure 3A ) but only a very modest increase in Ad.545-transduced cells. Likewise, knockdown of ARC by siRNA completely prevented the 5-hydroxytryptamine (serotonin)-induced hypertrophy [13] [14] [15] of isolated PASMCs ( Figure 3B ). Thus, in addition to its role in suppressing cell death, ARC is also required for mitogenic and hypertrophic growth of PASMCs.
Reduction in the expression of the regulatory ␣-subunits of selected voltage-gated potassium (K v ) channels (eg, K v 1.5, K v 1.6, K v 2.1, and K v 9.3) is a hallmark of human pulmonary hypertension and multiple animal models of this syndrome. 9, 10, 23, 31 Whereas decreases in K v channel activity caused by acute hypoxia have been linked to vasoconstriction, 32 exposure of Ad.Neg-transduced PASMCs to CH (72 hours) caused a significant decrease in the mRNA levels of mRNAs encoding the regulatory ␣-subunits of K v 9.3 (Kcns3), K v 1.6 (Kcna6), K v 1.5 (Kcna5), and K v 2.1 (Kcnb1) channels ( Figure 3D ), similar to previous reports. [31] [32] [33] [34] Although knockdown of ARC (Ad.545) had no effect on the hypoxia-induced downregulation of Kcns3, it ablated the hypoxia-induced decrease in Kcna6 and actually augmented levels of transcripts for Kcna5 and Kcnb1. As the downregulation of K v channel expression has been linked to increased proliferation and apoptosis-resistance, 33 these data along, with those in Figure 3A and 3B demonstrate that ARC supports an apoptosis-resistant and growth-promoting environment for PASMCs.
ARC-Deficient Mice Are Resistant to Chronic Hypoxia-Induced Pulmonary Hypertension
The progrowth and prosurvival effects of ARC on PASMCs suggest a role for ARC in CH-induced pulmonary hypertension in vivo. To test this hypothesis, we created mice with germline deletion of nol3, the gene encoding ARC (online-only Data Supplement Figure III) . Western blotting of lung extracts and immunostaining of lung tissue sections demonstrate the complete absence of ARC protein expression in null mice (online-only Data Supplement Figure IIIC and IIID) .
Under normoxic (N) conditions, nol3 ϩ/ϩ (wild-type, WT), and nol 3 Ϫ/Ϫ (knockout, KO) mice had similar baseline hemodynamic characteristics (online-only Data Supplement Table II ) and exhibited similar changes in hematocrit in response to CH (online-only Data Supplement Figure IIIE) . However, whereas CH induced a significant elevation in mean pulmonary arterial and RV systolic pressures in WT mice, only modest increases were observed in KO mice ( Figure 4A and 4B and online-only Data Supplement Table II ). In a similar manner, the right ventricles of CH-WT mice exhibited hypertrophy that was more prominent than that seen in CH-KO mice ( Figure  4F ). CH-WT mice also exhibited a substantial decrease in cardiac output (CO) and the various indices dependent on it (contractility index and pulmonary vascular resistance) ( Figure 4D and 4E) , whereas CO in CH-KO mice was not statistically different from that in N-KO controls ( Figure  4C ). Overall, these data show that the hemodynamic response to CH-induced pulmonary hypertension was markedly attenuated in the ARC KO mouse. 
Absence of ARC Attenuates Hypoxia-Induced Remodeling of the Pulmonary Vasculature
The marked reduction in PAP, RVSP, and RV hypertrophy in CH-KO mice suggest that CH-induced vascular remodeling may be reduced in KO compared to WT mice. Pulmonary vascular changes in chronic hypoxic mice include moderate thickening (25%-100%) of the medial cell layer of resistance pulmonary arteries and neomuscularization of more distal vessels. Figure 5A shows representative images of medial thickening in small vessels (Ͻ50 mol/L) of CH-WT and CH-KO mice, as delineated by the space between opposing arrows. Although no significant differences in medial thickness were observed between WT and KO mice under normoxic conditions, CH induced a near doubling in medial thickness in WT mice while eliciting only a Ϸ30% increase in KO mice ( Figure 5B) .
Neomuscularization of distal arteries in response to CH was assessed by scoring von Willebrand factor (vWF)-positive vessels as either fully (FM), partially (PM), or non (NM) muscularized. Only arterioles adjacent to alveoli were selected for analysis because these are, in general, Ͻ50 m in diameter. The images in Figure 5C show examples of each category, while the combined data from the analysis of the vessels show that CH dramatically increased the proportion of PM and FM vessels in WT mice at the expense of NM vessels, indicative of increased neomuscularization ( Figure   5D ). In contrast, these changes were significantly blunted in CH-KO mice and not statistically different from N-KO mice. These data show that vascular remodeling of resistance vessels in CH-KO mice is significantly reduced from that seen in CH-WT mice, demonstrating that endogenous levels of ARC are critical for CH-induced remodeling of pulmonary vessels.
Absence of ARC Interferes With Cellular Processes That Mediate Pulmonary Vascular Remodeling In Vivo
To identify cellular mechanisms through which ARC promotes pulmonary vascular remodeling in vivo, we assessed the effects of its absence on apoptosis and proliferation in small intrapulmonary vessels of CH mice. Although baseline apoptosis was not significantly affected by loss of ARC ( Figure 6E ), CH-increased apoptosis in both small (Ͻ50 m) and larger (50 -200 m) intrapulmonary vessels was markedly elevated in KO versus WT mice ( Figure 6A through 6E) . Similarly, the absence of ARC severely curtailed hypoxiainduced increases in the percentage of PCNA-positive cells in both small and larger intrapulmonary vessels PASMCs in vivo, without affecting baseline levels ( Figure 6F through  6K) . Taken together, these data show that ARC suppresses cell death and stimulates proliferation in the distal vasculature to promote vascular remodeling. In Figure 3D , we showed that ARC plays an essential role in the CH-induced downregulation of the mRNAs encoding select hypoxia-sensitive Kv channels in isolated PASMCs. We show that in Figure 7 absence of ARC expression in vivo also prevented the CH-induced decreases in the expression of K v 1.6, K v 1.5, and K v 2.1 regulatory subunits in intact distal vessels without influencing baseline levels ( Figure 7) . As in the cell culture experiments (Figure 3D ), lack of ARC did not prevent the CH-induced downregulation of K v 9.3 transcripts. These data show that endogenous levels of ARC are critical for the chronic hypoxia-induced downregulation of mRNAs encoding select Kv channels in response to hypoxia in vivo.
ARC Is a Component of Human Pulmonary Hypertension
The in vitro and in vivo loss of function studies demonstrate that absence of ARC disrupts CH-induced remodeling of the pulmonary arterial vasculature in the mouse. To explore a possible role for ARC in human PH, immunohistochemical analyses were performed on lung tissue obtained from patients undergoing surgical biopsy to evaluate a lung nodule (controls; N1-N4) and explants from patients with WHO group I pulmonary arterial hypertension undergoing lung transplantation (PH1-PH5). The official pathological assessment confirmed normal lung architecture in the controls and changes consistent with PH in the explanted lungs. In controls, there was little to no staining for ARC in the vessel wall or lumen ( Figure 8A ). In contrast, 4 of the 5 PH samples showed robust staining in both muscularized vessels ( Figure  8B , black arrows) and lumen-occluding lesions ( Figure 8C , white arrows) associated with severe PAH in humans ( Figure  8B ). Thus, ARC abundance is markedly increased in the remodeled vessels of patients with PH. The high level of ARC expression in these lesions is remarkable but not unexpected, as ARC is highly expressed in many different cancers, [27] [28] [29] [30] and others have characterized the lumenoccluding lesions in severe PH as having multiple cancer-like properties. 35 
Discussion
Suppression of cellular apoptosis and increased proliferation has been proposed as essential mechanisms in the remodeling of the pulmonary vasculature associated with PH. 23, 33, 36, 37 We show here for the first time that ARC, a suppressor of multiple forms of cell death, is expressed in the medial smooth muscle cells of the pulmonary vasculature of both mice and rats. In addition, we found that ARC's expression was markedly increased in the pulmonary arteries and resistance arterioles in different experimental models of PAH and in the pathological vascular lesions observed in patients with PAH ( Figures 1 through 4 and 8 ; Online-only Data Supplement Figure I ). The absence of ARC in isolated PASMCs (1) sensitized them to hypoxia-induced cell death ( Figure 2D ), (2) reduced their responsiveness to the growth-promoting effects of ET-1 and 5-HT ( Figure 3A and 3B), and (3) reversed the CH-induced suppression of select hypoxiasensitive K v channel subunits ( Figure 3C ). All of these attributes are consistent with a role for ARC in promoting pathological vascular remodeling in PH. This role is further supported by the demonstration that ARC-deficient (nol3 Ϫ/Ϫ ) animals have a markedly attenuated hemodynamic response to CH that is associated with reduced vascular remodeling, increased vascular cell apoptosis, and decreased vascular cell proliferation. Collectively, this work provides strong evidence in support of a critical role for ARC as a previously unrecognized determinant of the pathological vascular remodeling in CH-induced PH.
The mechanism(s) through which ARC promotes vascular remodeling in PH may be its ability to induce a state of marked apoptosis resistance in cells. 18 -22 When expressed in PASMCs, ARC upsets the balance between vascular cell growth and death in favor of increased muscularization of the vasculature. ARC, however, is not unique in this regard, as other antiapoptosis/prosurvival molecules, such as survivin (Birc5), 23 Bcl2, 36 and Bcl xl 37 have also been implicated in PH. While the upregulation of multiple death repressors in PH is a strong testament to the importance of suppressing cell death in the progression of this disease, it is not clear if these repressors have redundant, interdependent, or unique roles.
ARC, however, is unique among this cadre of death repressors in that it is also a critical regulator of PASMC growth ( Figure 3A and 3B) . The mechanism(s) underlying the ARC's progrowth effects have not been established, although recent studies have revealed that ARC functionally inactivates p53 in several cancer cell lines, thereby indirectly promoting cell growth. 38 As p53 can also suppress ARC expression, 39 a dynamic antagonism may exist between the two molecules to strictly control and fine-tune PASMC growth and death. This antagonism is apparent in vivo in the opposite responses to CH in mice deficient for ARC (reduced CH-PH) or p53 (exaggerated CH-PH). 40 We also show that ARC is necessary for the hypoxiainduced downregulation of mRNAs encoding the regulatory subunits of select K v channels ( Figures 3C and 7) , placing ARC upstream of changes in K v channel expression. A connection between ARC and K v channel activity was suggested by Ekheterae et al, 41 who observed chronic suppression of K v channel activity in ARC-overexpressing cells, although the molecular basis of this effect was not elucidated. Our data clearly show that ARC can suppress the accumulation of mRNAs encoding select K v channels ( Figures 3C and  7) . One mechanism through which ARC might affect K v channel mRNA abundance is its regulation of endothelin-1 signaling ( Figure 3A) , as this pathway has been shown to link CH to K v channel expression. 42 Interestingly, the other antiapoptosis/prosurvival proteins implicated in PH (survivin and Bcl-2) also promote decreased K v channel activity and/or expression. 23, 43 Although these molecules and ARC are structurally unrelated, a common denominator among them is their ability to prevent depolarization of the mitochondrial membrane potential (⌬ m ). 22, 44, 45 This suggests that changes in select K v channel activity and/or expression may be closely linked to changes in ⌬ m . If so, ARC on its own or in concert with survivin and/or Bcl2 would promote a more hyperpolarized ⌬ m , resulting in reduced expression/activity of select K v channels, perhaps through changes in mitochondrial reactive oxygen species production, as proposed by others. 46, 47 Our study has some limitations. CH in the mouse produces relatively mild PH with few of the histological landmarks (eg, lumen-occluding lesions) characteristic of human PH. Our studies on ARC, however, provide an important connection to the pathobiology of human PH as we demonstrate increased ARC expression within the apoptosis-resistant lumenoccluding lesions in the pulmonary arteries of PH patients (Figure 8) . Also, while ARC is expressed in the heart, the separate contributions of ARC deficiency on vasculature remodeling and right heart function cannot be ascertained from our current genetic model, a concern because others have shown that deficiency of ARC in the left ventricle leads to reduced contractile performance and decreased cardiac output in response to sustained pressure overload. 48 This does not, however, exclude direct effects of ARC deficiency on RV function, the presence of which would be best addressed by examining the effects of fixed pulmonary arterial stenosis in WT and KO mice.
In summary, we have shown that ARC is a novel upstream regulator of several critical factors implicated in the development of PH and that suppression of ARC in vivo protects mice from CH-induced PH. These effects of ARC are also likely to be important to human PAH as patient data show that ARC is expressed in the lumen-occluding lesions of severe human PH. Additional studies are needed to determine the role of ARC in other animal models of PH and how signaling through ARC integrates with other molecular signaling pathways contributing to PH. 
